Detalles de la búsqueda
1.
Implantable cardioverter defibrillator and cardiac resynchronization treatment in people with type 2 diabetes: a comparison with age- and sex matched controls from the general population.
Cardiovasc Diabetol
; 23(1): 18, 2024 01 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38184588
2.
Sex differences in the association between insulin resistance and non-fatal myocardial infarction across glycaemic states.
Cardiovasc Diabetol
; 23(1): 25, 2024 01 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38218814
3.
CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomes.
Cardiovasc Diabetol
; 23(1): 104, 2024 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38504284
4.
Primary apical periodontitis correlates to elevated levels of interleukin-8 in a Swedish population: A report from the PAROKRANK study.
Int Endod J
; 57(1): 12-22, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38290211
5.
Empagliflozin improves insulin sensitivity in patients with recent acute coronary syndrome and newly detected dysglycaemia : Experiences from the randomized, controlled SOCOGAMI trial.
Cardiovasc Diabetol
; 22(1): 208, 2023 08 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37568149
6.
Data from network meta-analyses can inform clinical practice guidelines and decision-making in diabetes management: perspectives of the taskforce of the guideline workshop.
Cardiovasc Diabetol
; 22(1): 277, 2023 10 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37833776
7.
CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes.
Cardiovasc Diabetol
; 22(1): 59, 2023 03 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36927451
8.
Gender differences in cardiovascular risk, treatment, and outcomes: a post hoc analysis from the REWIND trial.
Scand Cardiovasc J
; 57(1): 2166101, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36723445
9.
Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohort.
Cardiovasc Diabetol
; 21(1): 129, 2022 07 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35804351
10.
Plasma mannose as a novel marker of myocardial infarction across different glycaemic states: a case control study.
Cardiovasc Diabetol
; 21(1): 195, 2022 09 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36151569
11.
Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomes.
Cardiovasc Diabetol
; 21(1): 50, 2022 04 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35395808
12.
Dulaglutide and incident atrial fibrillation or flutter in patients with type 2 diabetes: A post hoc analysis from the REWIND randomized trial.
Diabetes Obes Metab
; 24(4): 704-712, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34984808
13.
Long-term prognosis after a first myocardial infarction: eight years follow up of the case-control study PAROKRANK.
Scand Cardiovasc J
; 56(1): 337-342, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35974709
14.
Endodontic inflammatory disease: A risk indicator for a first myocardial infarction.
Int Endod J
; 55(1): 6-17, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34561889
15.
Similar cardiovascular outcomes in patients with diabetes and established or high risk for coronary vascular disease treated with dulaglutide with and without baseline metformin.
Eur Heart J
; 42(26): 2565-2573, 2021 07 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33197271
16.
Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease: Insights From the COMPASS Trial.
Circulation
; 141(23): 1841-1854, 2020 06 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32223318
17.
Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveys.
Cardiovasc Diabetol
; 20(1): 38, 2021 02 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33573665
18.
Copeptin is associated with mortality in elderly people.
Eur J Clin Invest
; 51(7): e13516, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33569762
19.
Applying REWIND cardiovascular disease criteria to SUSTAIN 6 and PIONEER 6: An exploratory analysis of cardiovascular outcomes with semaglutide.
Diabetes Obes Metab
; 23(7): 1677-1680, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33606902
20.
Medical Treatment in Coronary Patients: Is there Still a Gender Gap? Results from European Society of Cardiology EUROASPIRE V Registry.
Cardiovasc Drugs Ther
; 35(4): 801-808, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33068226